Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia

Código QR

Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia

Yasunori Oda,1 Nobuhisa Kanahara,2 Hiroshi Kimura,1 Hiroyuki Watanabe,2 Kenji Hashimoto,3 Masaomi Iyo1 1Department of Psychiatry, Chiba University Graduate School of Medicine, Chiba, Japan; 2Division of Medical Treatment and Rehabilitation, 3Division of Clinical Neuroscience, Chiba University Cente...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Oda Y, Kanahara N, Kimura H, Watanabe H, Hashimoto K, Iyo M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/3c0baeec298e466c893d54ad07d6d8b9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Lack of beta-arrestin signaling in the absence of active G proteins
por: Manuel Grundmann, et al.
Publicado: (2018)

Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study
por: Hashimoto T, et al.
Publicado: (2015)

NMDA receptor regulation of levodopa-induced behavior and changes in striatal G protein-coupled receptor kinase 6 and ß-arrestin-1 expression in parkinsonian rats
por: Wu N, et al.
Publicado: (2013)

Odor perception and hedonics in chronic schizophrenia and in first episode psychosis
por: Urban-Kowalczyk M, et al.
Publicado: (2019)

Cycloid psychoses in the psychosis spectrum: evidence for biochemical differences with schizophrenia
por: van de Kerkhof NW, et al.
Publicado: (2016)

No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis
por: Maria Lee, et al.
Publicado: (2021)

Recurrent schizophrenia-like psychosis as first manifestation of epilepsy: a diagnostic challenge in neuropsychiatry
por: Willem MA Verhoeven, et al.
Publicado: (2010)

The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study
por: Hashimoto K, et al.
Publicado: (2014)

Structural Basis of Arrestin Selectivity for Active Phosphorylated G Protein-Coupled Receptors
por: Preethi C. Karnam, et al.
Publicado: (2021)

Cannabis-induced psychosis masquerading schizophrenia or vice-versa? A diagnostic dilemma
por: Rachit Sharma, et al.
Publicado: (2021)

Association of dopamine D1 receptor gene polymorphism with schizophrenia: a meta-analysis
por: Pan YQ, et al.
Publicado: (2014)

Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients
por: Altintas M, et al.
Publicado: (2016)

Late ‘Early Intervention in Psychosis’: A Family School for Learning How to Live with Schizophrenia
por: Heinz Katschnig, et al.
Publicado: (2021)

Distinct G protein-coupled receptor phosphorylation motifs modulate arrestin affinity and activation and global conformation
por: Daniel Mayer, et al.
Publicado: (2019)

Clinical Validity of Subjective Clinical Prognosis in First Episode Psychosis Schizophrenia Patients: An Analysis of Data from the European First Episode Schizophrenia Trial (EUFEST) Study
por: Matei VP, et al.
Publicado: (2020)

Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor
por: David L. Gray, et al.
Publicado: (2018)

Impaired reach-to-grasp kinematics in parkinsonian patients relates to dopamine-dependent, subthalamic beta bursts
por: Matteo Vissani, et al.
Publicado: (2021)

Hummingbird Study: Results from an Exploratory Trial Assessing the Performance and Acceptance of a Digital Medicine System in Adults with Schizophrenia, Schizoaffective Disorder, or First-Episode Psychosis
por: Fowler JC, et al.
Publicado: (2021)

Monitoring G protein-coupled receptor and β-arrestin trafficking in live cells using enhanced bystander BRET
por: Yoon Namkung, et al.
Publicado: (2016)

Differential methylation of enhancer at IGF2 is associated with abnormal dopamine synthesis in major psychosis
por: Shraddha Pai, et al.
Publicado: (2019)

Dopamine and Neuroinflammation in Schizophrenia – Interpreting the Findings from Translocator Protein (18kDa) PET Imaging
por: Iliopoulou SM, et al.
Publicado: (2021)

Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia
por: Frydecka D, et al.
Publicado: (2015)

Intergeneration Transmission of Violence in Forensic Patients With a Diagnosis of Schizophrenia and Psychosis: Was Parental Alcoholic Abuse a Significant Factor?
por: Milena Petrovic, et al.
Publicado: (2021)

Isoform specific differences in phospholipase C beta 1 expression in the prefrontal cortex in schizophrenia and suicide
por: M. Udawela, et al.
Publicado: (2017)

Psychosis in parkinsonism: an unorthodox approach
por: Onofrj M, et al.
Publicado: (2017)

The Relationship Between Antipsychotic Treatment and Plasma β-Endorphin Concentration in Patients with Schizophrenia
por: Urban-Kowalczyk M, et al.
Publicado: (2021)

The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia
por: Urban-Kowalczyk M, et al.
Publicado: (2020)

Associations between dopamine D2 receptor gene polymorphisms and schizophrenia risk: a PRISMA compliant meta-analysis
por: He HR, et al.
Publicado: (2016)

Potential link between genetic polymorphisms of catechol-O-methyltransferase and dopamine receptors and treatment efficacy of risperidone on schizophrenia
por: Han JY, et al.
Publicado: (2017)

Psychosis in behavioral variant frontotemporal dementia
por: Gossink FT, et al.
Publicado: (2017)

Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia
por: Urban-Kowalczyk M, et al.
Publicado: (2016)

Solifenacin-induced acute psychosis: a case report
por: Betul Kirsavoglu, et al.
Publicado: (2021)

Affective temperaments of Lebanese patients with schizophrenia: comparison by gender and severity of psychosis
por: Joseph E. Dib, et al.
Publicado: (2021)

Neuroleptic-induced deficit syndrome in bipolar disorder with psychosis
por: Ueda S, et al.
Publicado: (2016)

Depression Predicts Global Functional Outcomes in Individuals at Clinical High Risk for Psychosis
por: Wisteria Deng, et al.
Publicado: (2021)

Markers of neurodevelopmental impairments in early-onset psychosis
por: Petruzzelli MG, et al.
Publicado: (2015)

Neonatal disruption of serine racemase causes schizophrenia-like behavioral abnormalities in adulthood: clinical rescue by d-serine.
por: Hiroko Hagiwara, et al.
Publicado: (2013)

Myxedema Psychosis: Systematic Review and Pooled Analysis
por: Mohamed MFH, et al.
Publicado: (2021)

Novel treatment options in depression and psychosis
por: Ceskova E, et al.
Publicado: (2018)

LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1
por: Ramona M. Rodriguiz, et al.
Publicado: (2021)